In a backside-covering move, the FDA has gone public with the “news” that it has nothing to report – yet – about possible heart risks for users of Nexium/Prilosec.
Yes, the FDA caught grief for not going public earlier with some data about Avandia. But what good is accomplished by raising issues like this when the data analysis is not complete? This is a P.R. move, not a sound clinical/regulatory decision. All it does is scare people.
If/when there is real and substantial evidence of a problem, then certainly get the word out. But let’s put science before lame attempts to deflect blame.
Leave a Reply